Warn Patients Not to Rely on OTC Primatene Mist for Asthma

January 2019

Primatene Mist (epinephrine) will return to OTC shelves for relieving mild symptoms of intermittent asthma in patients age 12 and up.

It was withdrawn in 2011 due to chlorofluorocarbon (CFC) propellant regulations, NOT safety issues. But most of us were happy to see it go.

Now Primatene Mist is back with an HFA propellant.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote